logo ininstituto Cajal

Home

linea

Spanish

linea

English

   
 
  Es tiempo de investigaci⊐D17Fn, es tiempo de vida, ....es tiempo de CSIC

Cómo llegar al instituto Cajal

biblioteca cajal

biblioteca cajal

  Intranet access
 

Intranet CSIC
Intranet Cajal

  banner Cajal

Home > News

Signing of an R&D contract to verify a possible therapeutic approach against Alzheimer's disease

29-11-2012

The CSIC has signed an R&D contract with the biotechnology company Tetraneuron for the development of agents able to block neuronal tetraploidization as a therapeutic method for Alzheimer's disease. This project will be carried out by the “Neuronal Generation and Degeneration in Vertebrates” group from the Cajal Institute as a “proof of concept” of a patent from this group, which has been licensed by Tetraneuron.

 


Home Cajal Institute Research Departments Support units for research Personnel Publications News Library Links intranet CSIC Contact Privacy and legal notices  
Av. Doctor Arce, 37. 28002 Madrid - Spain • Tel.: +34 915854750 • Fax.: +34 915854754 • Follow us on Twitter